Preparation, characterization and in vitro antimicrobial activity of ampicillin-loaded polyethylcyanoacrylate nanoparticles

被引:44
作者
Fontana, G
Pitarresi, G
Tomarchio, V
Carlisi, B
San Biagio, PL
机构
[1] Univ Palermo, Dipartimento Chim & Tecnol Farmaceut, I-90123 Palermo, Italy
[2] Univ Palermo, Ist Fis, I-90123 Palermo, Italy
关键词
polyethylcyanoacrylate; nanoparticle; ampicillin; antimicrobial activity;
D O I
10.1016/S0142-9612(97)00246-9
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
In this paper, the experimental conditions for preparing ampicillin-loaded polyethylcyanoacrylate (PECA) nanoparticles are described. The effects of drug concentration and surfactant type in the polymerization medium on the particle size distribution and loading capacity were studied. The results of these studies show that only the type of surfactant has an impact on the nanoparticle dimensions. The release rate of ampicillin from PECA nanoparticles at pH 7.4 (extracellular value pH) performed either with and without esterases, show that the drug release is considerably increased in the presence of these exzymes. The results of drug release study at pH 1.1 (simulated gastric juice) are very interesting. This study has evidenced that the 70% of ampicillin is released quickly, while the remaining fraction is firmly incorporated in nanoparticles. The,released ampicillin is quickly degraded in acid medium while the entrapped fraction is protected from acid degradation and afterwards, when nanoparticles reach the small intestine, can be readily released in the presence of esterases. This result could be exploited for the oral administration of the ampicillin-PECA system. Finally, studies of antimicrobial activity of prepared systems evidenced that ampicillin-loaded PECA nanoparticles exhibit an activity equal or higher than the free drug. (C) 1998 Published by Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:1009 / 1017
页数:9
相关论文
共 22 条
[1]   ENTRAPMENT OF BETA-LACTAMS ANTIBIOTICS IN POLYETHYLCYANOACRYLATE NANOPARTICLES - STUDIES ON THE POSSIBLE IN-VIVO APPLICATION OF THIS COLLOIDAL DELIVERY SYSTEM [J].
CAVALLARO, G ;
FRESTA, M ;
GIAMMONA, G ;
PUGLISI, G ;
VILLARI, A .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1994, 111 (01) :31-41
[2]   POLYALKYLCYANOACRYLATE NANOPARTICLES AS DRUG CARRIER - PRESENT STATE AND PERSPECTIVES [J].
COUVREUR, P ;
VAUTHIER, C .
JOURNAL OF CONTROLLED RELEASE, 1991, 17 (02) :187-198
[3]   TOXICITY OF POLYALKYLCYANOACRYLATE NANOPARTICLES .2. DOXORUBICIN-LOADED NANOPARTICLES [J].
COUVREUR, P ;
KANTE, B ;
GRISLAIN, L ;
ROLAND, M ;
SPEISER, P .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1982, 71 (07) :790-792
[4]  
COUVREUR P, 1986, POLYM NANOPARTICLES, P27
[5]  
COVREUR P, 1984, MICROSPHERES DRUG TH
[6]  
Davis S. S., 1984, MICROSPHERES DRUG TH
[7]   BIODISTRIBUTION OF POLY(BUTYL 2-CYANOACRYLATE) NANOPARTICLES IN RABBITS [J].
DOUGLAS, SJ ;
DAVIS, SS ;
ILLUM, L .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1986, 34 (1-2) :145-152
[8]   Preparation and characterization of polyethyl-2-cyanoacrylate nanocapsules containing antiepileptic drugs [J].
Fresta, M ;
Cavallaro, G ;
Giammona, G ;
Wehrli, E ;
Puglisi, G .
BIOMATERIALS, 1996, 17 (08) :751-758
[9]   PEFLOXACINE MESILATE-LOADED AND OFLOXACIN-LOADED POLYETHYLCYANOACRYLATE NANOPARTICLES - CHARACTERIZATION OF THE COLLOIDAL DRUG CARRIER FORMULATION [J].
FRESTA, M ;
PUGLISI, G ;
GIAMMONA, G ;
CAVALLARO, G ;
MICALI, N ;
FURNERI, PM .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1995, 84 (07) :895-902
[10]  
GOODMAN LS, 1990, PHARMACOL BASIS THER, P1550